Haloferax uolcanii acquires resistance to doxorubicin, and this acquisition involves an active extrusion of lipophilic drugs. We have investigated what this drug-efflux transporter utilizes as an energy source to expel drugs from the cells. The efflux activity was estimated from the direct measurement of drug efflux rate and from the steady-state level of drug accumulation. Cells treated with NJ'-dicyclohexyl-carbodiimide showed a significant decrease in the efflux activity without changing membrane potential and Naf-electrochemical potential. This efflux system is energized by ATP but not by either a H+-or Naf-electrochemical potential difference.
Introduction
In prokaryotic organisms, multi-drug resistance (MDR) mechanisms based on an active extrusion of various drugs have been found. Most of these mechanisms involve single integral membrane proteins that utilize the proton-motive force (pmf) to energize extrusion of various drugs from cells, acting, in other words, as a H+/drug antiporter. These transporters recognize various structurally unrelated antibiotics, thus conferring MDR. These include Bmr [1] in Bacillus subtilis, AcrE [2] and EmrB/D [3] in Es-M. Kornutsubartr et trl. / F&MS Microbiology Letters 139 (19%) [83] [84] [85] [86] [87] [88] lated lipophilic compounds from MDR cells, including (i) MDR acquisition, (ii> spectrum of drug recognition, (iii> energy-dependent efflux system, and (iv) inhibition of efflux by Ca'+-channel antagonists. Hence, we referred to this as a P-glycoprotein-like efflux transporter [9] . What this P-glycoprotein-like efflux transporter requires as an energy source has remained unknown. However, this efflux system unquestionably needs energy to extrude a drug.
This paper has aimed to clarify what energizes the drug-efflux system in H. ~&anii, and it is concluded that the system is energized by ATP hydrolysis, but not by either a H+-or Na+-electrochemical potential difference.
Materials and methods

Materials
N,N'-dicyclohexylcarbodiimide (DCCD) and firefly lantern extract were purchased from Sigma (St. Louis, MO). Phenazine methosulfate (PMS) was purchased from Nakarai Chemicals (Kyoto, Japan).
[3H]Alanine (33 Ci/mmol) was purchased from Amersham (Buckinghamshire, England). Rhodamine 123 (RHl23) and bis ( I ,3_dibutylbarbituric acidltrimethine oxonol (0X0) were purchased from Molecular Probes (Eugene, OR). 3-(N-morpholino)propanesulfonic acid (MOPS) was purchased by Dojindo Chemical Co. (Kumamoto, Japan). Doxorubicin was generously supplied by Kyowa Hakko Kogyo (Tokyo, Japan). All other reagents were commercial products of analytical grade.
Cell culture and cell preparation
Haloferax volcanii was purchased from the National Collections of Industrial and Marine Bacteria (Aberdeen, UK). We repeatedly cultured it in a standard medium containing 1.5 PM doxorubicin, and selected the doxorubicin-resistant mutant able to grow normally even in a doxorubicin medium [9] . Cells were grown under the same conditions as described in a previous report [9] . Bacteria in late-exponential growth were harvested. Cells were centrifuged at 9000 X g for 10 min, washed three times in 4.28 M NaCl, 50 mM MOPS buffer (pH 7.0) hereafter called uptake buffer, and suspended to an appropriate protein concentration. Protein was determined by Lowry's method [ 101 using bovine serum albumin as a standard.
E#hx and uccumulation of RH123 b?; cells
Since fluorescent RH123 is recognized by the P-glycoprotein-like efflux transporter [9] , RH 123 efflux was determined by flow cytometry. Cell suspension was diluted to 0.1 mg protein/ml with uptake buffer containing 2 mM ascorbate and 20 PM PMS. The respiratory substrate, ascorbate plus PMS was used as energy source. RH123 (final concentration, 8 PM) was preloaded into cells during 15 min incubation at 25°C. An aliquot (0.5 ml) of the loaded cell suspension was diluted in RH123-free uptake buffer ( 10 ml) containing 2 mM ascorbate and 20 PM PMS to start its efflux from the cells. RH123 remaining in the cells was determined in an EPICS CS, flow cytometer (Coulter Electronics, Hialeah, FL) (excitation: 488 nm; emission: 520 nm; bandwidth:
$5 nm) as reported [9] . Cell sample fluorescence intensity was calculated from the relative fluorescence intensity with data analysis software included.
RH123 accumulation was also determined, since the Huloferux drug-efflux activity negatively correlated with the accumulation [9] . Cell suspension (0.1 mg protein/ml) was incubated in the uptake buffer containing 2 mM ascorbate and 20 PM PMS for 5 min at 25°C. After preincubation, an aliquot of RH123 solution (final concentration: 0.15 PM) was added to start its accumulation. A 500 ,ul aliquot of cell suspension was taken at 15 min, and RH123 accumulation in cells was measured with the flow cytometer.
Membrane potential estimation
The membrane potential was estimated using a fluorescent probe, 0X0, which is not a substrate for the drug-efflux transporter [9] . After 5 min pre-incubation at 25°C an aliquot of OX0 solution (final concentration of 0.05 PM) was added to start the accumulation.
The intracellular fluorescence intensity was measured at 30 min with the flow cytometer (excitation, 488 nm; emission, 560 nm; bandwidth, f5 nm) as described for RH123. We used lo-"% Triton X-100 to depolarize membrane. 1 Om4 % Triton X-100 did not interfere with the fluorescence measurement.
Treatment of cells with DCCD
Cell suspensions (2 mg protein/ml] were incubated in the presence of lo-150 FM DCCD at 4°C overnight without stirring. Before use the cells were centrifuged at 9000 X g for 10 min and resuspended in the uptake buffer containing 2 mM ascorbate and 20 PM PMS. The protein concentration was adjusted to 0.1 mg/ml.
Alanine accumulation
Accumulation of alanine by cells was measured by a filtration method utilizing 3H-labelled compounds [I I]. An aliquot of labelled compound (4-5 @I) was added to the cell suspension as described above (final concemmtion: alanine, 1 PM) to start the accumulation of the labelled compound. A 200 ~1 aliquot of cell suspension was taken at given times (1, 2, 3, 4, 5 min), and immediately added to 10 ml of ice-cooled 4.28 M NaCl solution, followed by rapid filtration with a Whatman FG/B filter (Whatman International, Maidstone, UK), then washed twice with 10 ml of ice-cooled 4.28 M NaCl solution. The filter was transferred to a scintillation vial and shaken for 20 min with 2 ml of 10% Triton X-100. Radioactivity was measured in a ACS-II scintillation cocktail (Amersham Corp., Arlington Heights, MA) with a Packard 460C liquid scintillation counter. The binding of compounds to the filter was corrected by subtracting radioactivity of control experiments without cells from the sample counts. This correction amounted at most to 4% when the uptake was small, and it was negligible when sufficient uptake by cells was observed.
Preparation of envelope vesicles and transport experiment
Envelope vesicles were prepared as described previously [l 11. The preparation method was the same as that used for Halobacterium hulobium developed by MacDonald and Lanyi [ 121. The ion contents in the vesicles were changed to the desired salt of 3 M composition by the osmotic-dilution method [ 11,121. Experimental procedures of transport were the same as those for intact cells. The transport activity remained unchanged for at least one month provided that the vesicles were kept at 4°C.
Measurement of intracellular ATP level
Cells (0.1 mg protein/ml) were incubated in uptake buffer (pH 7.0) at 25°C for 15 min. A one ml aliquot of cell suspension was centrifuged for 1 min in a table-top microfuge (Kubota Industry, Tokyo, Japan). The precipitate was then treated with 2 ml of 5% perchloric acid, and cellular ATP was extracted. After neutralization by 1 M KOH and centrifugation at 3000 rpm for 15 min, ATP content in the supernatant was determined with a 54-7741 Chem-Glo Photometer (American Instrument, Silver Spring, MD), utilizing firefly lantern extract [ 131. Intracellular ATP level was expressed as nmol/mg protein cells.
Results and discussion
In order to determine what energizes the efflux system, we monitored RI-I123 efflux and accumulation by cells, which were incubated overnight at 4°C with an ATPase inhibitor, DCCD at various concentrations (4-150 PM). ATP contents in 150 /.LM DCCD-treated and non-treated cells were 0.60 & 0.06 and 2.87 f 0.12 nmol/mg protein (mean f S.E., n = 5), respectively. The intracellular ATP was remarkably depleted by 150 PM DCCD. The changes in membrane potential under DCCD-treated conditions were estimated by a membrane potential probe, OX0 [9, 14] . OX0 fluorescence intensity was increased in cells by membrane depolarization with 1 0m4 % Triton X-100 (Table l), confirming that the change in OX0 fluorescence reflects that in the membrane potential. The membrane potential remained unchanged irrespective of DCCD under conditions in which the membrane was energized by respiration. By contrast, the efflux rate of RH123 remarkably declined (Fig. 1A) . Fig. 1B shows the substantial increase in the steady-state RH123 accumulation by DCCD-treated cells. It is noted that the accumulation negatively correlated with the efflux activity [9] . These results imply that a H+-electrochemical potential difference across the membrane is not involved in the energization of the RH 123 efflux.
We determined the effect of DCCD on a Na+-electrochemical potential difference by monitoring alanine uptake by cells. Fig. 2 shows the uptake of Ala by envelope vesicles. Ala was accumulated by 3 M KCl-loaded vesicles only when there was 3 M NaCl in the outside medium. Ala uptake was enhanced by the addition of the respiration substrate, ascorbate plus PMS, which generates interior negative membrane potential. The nutrient uptake was thus confirmed to reflect membrane potential as well as a Nat-electrochemical potential difference. The uptakes by the resistant cells treated with DCCD revealed the control level: the uptake rates in the resistant cells with and without DCCD treatment were 0.26 k 0.03 and 0.25 -t 0.04 nmol/min/mg protein (mean * S.E., n = 4), respectively. The uptake by wild-type cells also remained unchanged irrespective of DCCD; the uptake rates in the wildtype cells with and without DCCD treatment were 0.21 * 0.05 and 0.23 _t 0.03 nmol/min/mg protein (mean &-S.E., n = 41, respectively. DCCD slightly affected the Na+-electrochemical potential. Thus, results in Fig. 1 are incompatible with the notion that the efflux system is energized by an ion-electrochemical potential. 
*
The experimental medium and the conditions were the same as those described in the legend to Fig. 1 Alternatively, we found a negative correlation between the intracellular ATP concentration and RH123 accumulation (Fig. 31 , where it is noted that ion electrochemical potentials remained unaltered. This strict relationship implies the involvement of ATP in the energization of the efflux system. Thus, we concluded that the transporter is energized by ATP hydrolysis. The properties of the ATP-dependent drug-efflux transporter delineated in H. uolcanii are analogous to those associated with MDR-related P-glycoprotein in mammals [15-171. In both cases, there is evidence of their function in outwardly directed flux of cytotoxic agents and their identity as an ATP-dependent efflux system. Also, both systems were inhibited by DCCD and the MDR modulators, verapamil, nifedipine, reserpine and monensin. Furthermore, the drugefflux system recognizes lipophilic cations that Pglycoprotein recognizes as substrate, including doxorubicin, vincristine, vinblastine and RH123 [9] . It now seems possible that the ATP-dependent efflux we have elucidated may have homology to P-glycoprotein, and may belong to the ATP binding cassette family of membrane proteins. Further investigations of the drug-efflux transporter gene and analysis of its sequence are required to address the similarity and dissimilarity between mammalian P-glycoprotein and the P-glycoprotein-like drug-efflux transporter in H. uolcanii.
ATP content (% ot control) Fig. 3 . Relationship between RH123 accumulation and intracellular ATP content in resistant cells. Resistant cells were incubated at 4°C overnight with 10 to 150 FM DCCD. Before use, the cells were centrifuged as described in Section 2, and resuspended in the uptake buffer containing 2 n&l ascorbate and 20 FM PMS. RH123 accumulation was determined as described in the legend to Fig. 1 
